AbbVie’s Q1 earnings beat expectations as arthritis drug boosts growth

Pharmaceuticals company AbbVie (NYSE: ABBV) reported its Q1 financial results for 2024 today. AbbVie’s earnings came in at $1.37 billion, or $0.77 per share, as compared with $239 million, or $0.13 per share, in Q1 of FY23. The company’s revenue reached $12.31 billion, with an increase of 0.7% on a reported basis, or 1.6% on […]